banner add

Officials Cast Doubt on a Dementia Drug, but Human Trials Continue

The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.

from NYT > Health https://ift.tt/HO1FV4S
via IFTTT

No comments

RFK Jr. Allies Target States to Overturn Vaccine Mandates for Schools

Proponents of vaccines warn that the efforts will further dismantle the immunization infrastructure and lead to more outbreaks of disease. ...

Theme images by PLAINVIEW. Powered by Blogger.